Myeloid-Derived Suppressor Cells: Facilitators of Cancer and Obesity-Induced Cancer

Suzanne Ostrand-Rosenberg
2020 Annual Review of Cancer Biology  
Immature myeloid cells at varied stages of differentiation, known as myeloid-derived suppressor cells (MDSC), are present in virtually all cancer patients. MDSC are profoundly immune-suppressive cells that impair adaptive and innate antitumor immunity and promote tumor progression through nonimmune mechanisms. Their widespread presence combined with their multitude of protumor activities make MDSC a major obstacle to cancer immunotherapies. MDSC are derived from progenitor cells in the bone
more » ... ow and traffic through the blood to infiltrate solid tumors. Their accumulation and suppressive potency are driven by multiple tumor- and host-secreted proinflammatory factors and adrenergic signals that act via diverse but sometimes overlapping transcriptional pathways. MDSC also accumulate in response to the chronic inflammation and lipid deposition characteristic of obesity and contribute to the more rapid progression of cancers in obese individuals. This article summarizes the key aspects of tumor-induced MDSC with a focus on recent progress in the MDSC field. Expected final online publication date for the Annual Review of Cancer Biology, Volume 5 is March 4, 2021. Please see for revised estimates.
doi:10.1146/annurev-cancerbio-042120-105240 fatcat:zqbxkvafrncq7ixtwu2fdw6wlm